Certificate under Regulation 74(5) of (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025. This is a routine regulatory filing in which the company confirms to the depositories (NSDL/CDSL) that the details of securities held in dematerialized form by its shareholders have been properly reconciled. It essentially certifies that the company's share records match with the depository records for that quarter. No new business, financial, or operational information is disclosed in this filing.
This is a standard compliance submission with no material effect on the company's financials, operations, or stock price. Investors can ignore it as routine housekeeping required of all listed companies each quarter.